Implantable device for treating hypervolemia

By designing an implantable device, the use of semipermeable membrane and pump actuation mechanism to absorb and discharge water from body fluids, the problem of peritoneal cavity accumulation caused by excessive blood volume is solved, shortness of breath and hypertension are alleviated, and the patient's life is improved. quality.

CN112912118BActive Publication Date: 2024-11-26BARD PERIPHERAL VASCULAR INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980070404.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-10-24
Filing Date
2019-10-24
Publication Date
2024-11-26
Estimated Expiration
2039-10-24

AI Technical Summary

Technical Problem

The accumulation of the peritoneal cavity and pleural cavity caused by excessive blood volume causes shortness of breath and hypertension, which aggravates heart disease in severe cases, and the existing technology is difficult to effectively control.

Method used

An implantable device is designed, including an expandable chamber, a rigid chamber, a valve and a permeable fluid, which absorbs water from the body fluid using a semipermeable membrane, drains water through a pump actuation mechanism, and the device can be implanted into the peritoneal cavity or The ureter is used to drain excess water.

Benefits of technology

Effectively reduce blood volume, relieve shortness of breath and hypertension, improve patients' quality of life, and reduce the risk of heart stress.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112912118B_ABST
    Figure CN112912118B_ABST
Patent Text Reader

Abstract

An implantable device for treating hypervolemia includes: an expandable chamber; a rigid chamber coupled to the expandable chamber; a first valve in fluid communication with both the expandable chamber and the rigid chamber; a second valve in fluid communication with the rigid chamber and an exterior of the implantable device; and an osmotic fluid. The expandable chamber includes a first semipermeable membrane. The rigid chamber includes a piston. The first valve has an open position to allow fluid to flow between the expandable chamber and the rigid chamber. The second valve has an open position to allow fluid to flow from the rigid chamber to the exterior of the implantable device. The osmotic fluid has an osmotic concentration higher than that of body fluids. The osmotic fluid is designed to absorb water from body fluids through the first semipermeable membrane.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] priority

[0002] This application claims the benefit of priority to U.S. Provisional Application No. 62 / 750,138, filed on October 24, 2018, which is incorporated by reference in its entirety into this application. Background Art

[0003] Hypervolemia or fluid overload is a medical condition in which the volume of blood in the intravascular compartment exceeds normal levels due to excess water retained in the plasma. Water may accumulate in patients with chronic kidney disease, especially in advanced stages, such as end-stage renal disease ("ESRD"), where the kidneys no longer effectively filter out more water than the body needs. Water may also accumulate in patients with chronic heart disease, such as congestive heart failure ("CHF"), where the heart no longer effectively pumps blood to the kidneys to filter out more water than the body needs. Excessive blood volume in the intravascular compartment can lead to fluid accumulation in the peritoneal and pleural cavities, causing shortness of breath, which may reduce quality of life. Excessive blood volume in the intravascular compartment can also lead to high blood pressure and cardiac stress, which can exacerbate other diseases such as CHF, leading to death. Therefore, controlling hypervolemia is important for those suffering from medical conditions. Implantable devices and methods thereof that address the aforementioned problems are disclosed herein. Summary of the invention

[0004] Disclosed herein is an implantable device for treating hypervolemia, in some embodiments, the implantable device comprising: an expandable chamber; a rigid chamber coupled to the expandable chamber; a first valve in fluid communication with both the expandable chamber and the rigid chamber; a second valve in fluid communication with the rigid chamber and an exterior of the implantable device; and an osmotic fluid. The expandable chamber comprises a first semipermeable membrane. The rigid chamber comprises a piston. The first valve has an open position to allow fluid to flow between the expandable chamber and the rigid chamber. The second valve has an open position to allow fluid to flow from the rigid chamber to the exterior of the implantable device. The osmotic fluid has an osmotic concentration higher than that of body fluids. The osmotic fluid is designed to absorb water from body fluids through the first semipermeable membrane.

[0005] In some embodiments, the implantable device further comprises a pump. The pump is designed to move any fluid contents of the implantable device through the first valve in the open position or the second valve in the open position.

[0006] In some embodiments, the piston is configured to perform a pump-actuated pull stroke in the rigid chamber when the first valve is in the open position to pull any fluid contents of the expandable chamber into the rigid chamber.

[0007] In some embodiments, the piston is configured to perform a pump-actuated push stroke in the rigid chamber when the second valve is in the open position to push any fluid contents in the rigid chamber and expel permeate from the implantable device.

[0008] In some embodiments, at least one of the first semipermeable membrane or the second semipermeable membrane is a dialysis membrane.

[0009] In some embodiments, the permeating fluid is an aqueous solution of a dissolved polymer.

[0010] In some embodiments, the first semipermeable membrane and the second semipermeable membrane are designed to prevent the passage of an aqueous solution of a dissolved polymer.

[0011] In some embodiments, the implantable device is configured for implantation in the peritoneal cavity of a patient.

[0012] In some embodiments, the implantable device is shunted into the patient's ureters to drain excess water through the bladder.

[0013] In some embodiments, the implantable device further includes an induction coil configured to couple with a complementary induction coil of a companion device, wherein the companion device is operable to couple with a mains electricity to charge or power the implantable device by induction.

[0014] Also disclosed herein is an implantable device for treating hypervolemia, in some embodiments, the implantable device comprising: an expandable chamber; a rigid chamber including a piston; a first valve between the expandable chamber and the rigid chamber; a second valve between the rigid chamber and the exterior of the rigid chamber; and a fluid within the implantable device. The expandable chamber comprises a first semipermeable membrane located on at least a portion of the expandable chamber. The expandable chamber is configured to expand when a fluid is disposed in the expandable chamber and absorb water by osmosis from a body fluid outside the expandable chamber through the first semipermeable membrane, wherein the body fluid has a lower osmotic concentration. The first valve between the expandable chamber and the rigid chamber is configured to allow fluid to flow between the expandable chamber and the rigid chamber when the first valve is opened. The second valve between the rigid chamber and the exterior of the rigid chamber is configured to allow fluid to flow from the rigid chamber into the second semipermeable membrane when the second valve is opened so as to discharge water from the implantable device.

[0015] In some embodiments, the implantable device further comprises a pump. The pump is configured to operate in conjunction with both the first valve and the second valve. The pump is configured to move fluid between the expandable chamber and the rigid chamber when the first valve is opened, and the pump is configured to move fluid from the rigid chamber to the second semipermeable membrane when the second valve is opened.

[0016] In some embodiments, the piston is configured to perform a pump-actuated pull stroke in the rigid chamber to pull fluid from the expandable chamber into the rigid chamber when the first valve is open.

[0017] In some embodiments, the piston is configured to perform a pump-actuated push stroke in the rigid chamber when the second valve is open to push fluid from the rigid chamber through the second semipermeable membrane to expel water from the implantable device.

[0018] In some embodiments, the first semipermeable membrane, the second semipermeable membrane, or both the first and second semipermeable membranes are dialysis membranes.

[0019] In some embodiments, the fluid within the implantable device is an aqueous solution of a dissolved polymer.

[0020] In some embodiments, the fluid within the implantable device is an aqueous solution of a dissolved polymer that cannot pass through the first semipermeable membrane and the second semipermeable membrane.

[0021] In some embodiments, the implantable device is configured for implantation in the peritoneal cavity of a patient to remove water in excess of the patient's needs.

[0022] In some embodiments, the implantable device is shunted into the patient's ureters to drain more water through the bladder than the patient needs.

[0023] In some embodiments, the implantable device further includes an induction coil configured to couple with a complementary induction coil of a companion device, wherein the companion device is operable to couple with a power source to charge or power the implantable device by induction.

[0024] Also disclosed herein is an implantable device for treating hypervolemia, in some embodiments, the implantable device includes: a first expandable chamber, a second expandable chamber, a rigid chamber including a piston, a plurality of valves, and a fluid in the implantable device. The first expandable chamber includes a first semipermeable membrane located on at least a portion of the first expandable chamber. The second expandable chamber includes a second semipermeable membrane located on at least a portion of the second expandable chamber. Each of the first expandable chamber and the second expandable chamber is configured to expand when a fluid is placed therein and osmotic absorption of water from a body fluid outside the implantable device having a lower osmotic concentration. The plurality of valves include a first valve located between the first expandable chamber and the rigid chamber and a second valve located between the second expandable chamber and the rigid chamber. Each of the first valve and the second valve is configured to allow fluid to flow between adjacent chambers when the valve is opened. The plurality of valves also include a third valve located between the rigid chamber and the outside of the rigid chamber and a fourth valve located between the rigid chamber and the outside of the rigid chamber, wherein the third valve and the fourth valve are separated from each other by the piston. The third valve is configured to allow fluid to flow from the rigid chamber into the third semipermeable membrane to drain water from the implantable device when the third valve is opened. The fourth valve is configured to allow fluid to flow from the rigid chamber into the fourth semipermeable membrane to drain water from the implantable device when the fourth valve is opened.

[0025] In some embodiments, the implantable device further comprises a pump. The pump is configured to operate in conjunction with a plurality of valves. The pump is configured to move fluid between the first expandable chamber and the rigid chamber when the first valve is opened, and to move fluid from the rigid chamber to the fourth semipermeable membrane when the fourth valve is opened. The pump is also configured to move fluid between the second expandable chamber and the rigid chamber when the second valve is opened, and to move fluid from the rigid chamber to the third semipermeable membrane when the third valve is opened.

[0026] In some embodiments, the piston is configured to perform a pump-actuated pull stroke in the rigid chamber when the first valve and the fourth valve are open to simultaneously pull fluid from the first expandable chamber into the rigid chamber while pushing fluid from the rigid chamber through the fourth semipermeable membrane to expel water from the implantable device.

[0027] In some embodiments, the piston is configured to perform a pump-actuated push stroke in the rigid chamber when the second valve and the third valve are open to push fluid from the rigid chamber through the third semipermeable membrane to expel water from the implantable device and simultaneously pull fluid from the second expandable chamber into the rigid chamber.

[0028] In some embodiments, each of the first semipermeable membrane, the second semipermeable membrane, the third semipermeable membrane, and the fourth semipermeable membrane is a dialysis membrane.

[0029] In some embodiments, the fluid within the implantable device is an aqueous solution of a dissolved polymer.

[0030] In some embodiments, the fluid within the implantable device is an aqueous solution of a dissolved polymer that does not pass through the first, second, third, and fourth semipermeable membranes.

[0031] In some embodiments, the implantable device is configured for implantation in the peritoneal cavity of a patient to remove water in excess of the patient's needs.

[0032] In some embodiments, the implantable device is shunted into the patient's ureters to drain more water through the bladder than the patient needs.

[0033] In some embodiments, the implantable device further comprises an induction coil configured to couple with a complementary induction coil of a companion device, wherein the companion device is operable to couple with a power supply to charge or power the implantable device by induction.

[0034] Also disclosed herein is a method of treating hypervolemia using the aforementioned implantable device, the method comprising one or more of the functions described herein in connection with the implantable device for treating hypervolemia.

[0035] These and other features of the concepts provided herein will become more readily apparent to those skilled in the art in conjunction with the accompanying drawings and the following description, which more particularly disclose specific embodiments of these concepts. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1A An apparatus for treating hypervolemia is shown in a first stage of operation, according to some embodiments.

[0037] Figure 1B An apparatus for treating hypervolemia is shown in a second stage of operation, according to some embodiments.

[0038] Figure 1C An apparatus for treating hypervolemia is shown in a third stage of operation, according to some embodiments.

[0039] Figure 1D An apparatus for treating hypervolemia is shown in a fourth stage of operation, according to some embodiments.

[0040] Figure 1E An apparatus for treating hypervolemia is shown in a fifth stage of operation, according to some embodiments.

[0041] Figure 1F An apparatus for treating hypervolemia is shown in a sixth stage of operation, according to some embodiments.

[0042] Figure 2 Another device for treating hypervolemia is shown, according to some embodiments. DETAILED DESCRIPTION

[0043] Before disclosing some specific embodiments in more detail, it should be understood that the specific embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that the specific embodiments disclosed herein may have the following features, that is, it can be easily separated from the specific embodiments and optionally combined with or replaced with any of the features in many other embodiments disclosed herein.

[0044] About the term used herein, it should also be understood that these terms are for the purpose of describing some specific embodiments, and these terms do not limit the scope of the concept provided herein.Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify the different features or steps in a set of features or steps, and do not provide series or numerical restrictions.For example, "first", "second" and "third" features or steps do not need to appear in order, and the specific embodiment including these features or steps does not need to be limited to these three features or steps.For convenience, labels such as "left", "right", "front", "back", "top", "bottom" etc. are used, and these labels are not intended to imply, for example, any specific fixed position, orientation or direction.On the contrary, such marking is used to reflect, for example, relative position, orientation or direction.Unless the context clearly stipulates otherwise, "one", "a kind of" and "the" in the singular form include plural references.

[0045] Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.

[0046] As described above, hypervolemia or fluid overload is a medical condition in which the blood volume in the intravascular compartment exceeds normal levels due to excessive water retained in the plasma. Water may accumulate in patients with chronic kidney disease, especially in advanced stages, such as end-stage renal disease ("ESRD"), where the kidneys no longer effectively filter out water in excess of what the body needs. Water may also accumulate in patients with chronic heart disease, such as congestive heart failure ("CHF"), where the heart no longer effectively pumps blood to the kidneys to filter out water in excess of what the body needs. Excessive blood volume in the intravascular compartment can lead to fluid accumulation in the peritoneal and pleural cavities, causing shortness of breath, which may reduce quality of life. Excessive blood volume in the intravascular compartment can also lead to high blood pressure and cardiac stress, which can exacerbate other diseases such as CHF, leading to death. Therefore, controlling excessive blood volume is important for those suffering from medical conditions. An implantable device and method thereof that solves the aforementioned problems is disclosed herein.

[0047] Figures 1A-1F An apparatus 100 for treating hypervolemia in a number of different stages of operation is shown, according to some embodiments.

[0048] As shown in the figure, the implantable device 100 includes an expandable chamber 110, a rigid chamber 120 including a piston 122, a first valve 132 located between the expandable chamber 110 and the rigid chamber 120, a second valve 134 located between the rigid chamber 120 and the outside of the rigid chamber 120, and a fluid 140 within the implantable device 100.

[0049] The expandable chamber 110 includes a first semipermeable membrane 112 located on at least a portion of the expandable chamber 110. The expandable chamber 110 is configured to expand when a fluid 140 is disposed in the expandable chamber 110, and is configured to osmotically absorb water from a body fluid outside the expandable chamber 110 into the fluid 140 through the first semipermeable membrane 112, the body fluid outside the expandable chamber 110 having a lower osmotic concentration than the fluid 140. (See Appendix Figure 1A and 1B . )

[0050] The first valve 132 located between the expandable chamber 110 and the rigid chamber 120 is configured to have an open position so as to allow or permit the fluid 140 to flow between the expandable chamber 110 and the rigid chamber 120 when the first valve 132 is open or in the open position. Figure 1B and 1C . )

[0051] The second valve 134 located between the rigid chamber 120 and the exterior of the rigid chamber 120 is configured to have an open position so as to allow or permit fluid 140 to flow from the rigid chamber 120 into the second semi-permeable membrane 124 to drain water from the implantable device 100 when the second valve 134 is open or in the open position. Figure 1D and 1E . )

[0052] The implantable device 100 also includes a pump (not shown), such as a gear-driven piston pump, to move any fluid contents of the implantable device through the implantable device 100 (e.g., through the first valve 132 or the second valve 134 when in the open position). The pump is configured to operate in conjunction with both the first valve 132 and the second valve 134. The pump is configured to move the fluid 140 between the expandable chamber 110 and the rigid chamber 120 when the first valve 132 is open. The pump is also configured to move the fluid 140 from the rigid chamber 120 to the second semipermeable membrane 124 when the second valve 134 is open.

[0053] The piston 122 is configured to perform a pump-actuated pull stroke in the rigid chamber 120 when the first valve 132 is open to pull any fluid contents (e.g., fluid 140) from the expandable chamber 110 into the rigid chamber 120. The piston 122 is also configured to perform a pump-actuated push stroke in the rigid chamber 120 when the second valve 134 is open to push any fluid contents (e.g., fluid 140 from the rigid chamber 120) through the second semipermeable membrane 124 to expel water (as permeate) from the implantable device 100, thereby creating a retentate of fluid 140. Upon closing the second valve 134 or returning the second valve to a closed position, and opening the first valve 132 or returning the first valve 132 to an open position, the pump-actuated push stroke can be further used to push the retentate of fluid 140 from the rigid chamber 120 into the expandable chamber 110 for another cycle.

[0054] In addition to the above, the pump-actuated strokes may be applied in a cyclic mode of operation of the implantable device 100, wherein the fluid 140 is circulated back and forth between the expandable chamber 110 and the rigid chamber 120 through the first valve 132 when the first valve 132 is in the open position. The cyclic mode of operation ensures that the fluid 140 is mixed so that the osmotic concentration of the fluid 140 near the inner surface of the semipermeable membrane 124 remains high enough to permeate through the semipermeable membrane 124. Depending on the activity level of the patient in whom the implantable device 100 is implanted, the cyclic mode of operation of the implantable device 100 may not be necessary. That is, the patient's activity level may be sufficient to mix the fluid 140 to maintain a high enough osmotic concentration of the fluid 140 near the inner surface of the semipermeable membrane 124 to allow water to permeate through the semipermeable membrane 124.

[0055] Figure 2 Another device 200 for treating hypervolemia is shown according to some embodiments.

[0056] As shown, implantable device 200 includes a first expandable chamber 110 , a second expandable chamber 210 , a rigid chamber 120 including a piston 122 , a plurality of valves 132 , 134 , 232 , 234 , and a fluid 140 within implantable device 200 .

[0057] As described with reference to implantable device 100, first expandable chamber 110 includes first semi-permeable membrane 112 located over at least a portion of first expandable chamber 110. Likewise, additional second expandable chamber 210 includes second semi-permeable membrane 212 located over at least a portion of second expandable chamber 210. First expandable chamber 110 and second expandable chamber 210 are each configured to expand when fluid 140 is disposed therein, and are configured to osmotically absorb water from bodily fluids external to implantable device 200. That is, when the body fluid outside the expandable chamber 110 has an osmotic concentration lower than that of the fluid 140, the expandable chamber 110 expands when the fluid 140 in the expandable chamber 110 osmotically absorbs water from the body fluid outside the expandable chamber 110 into the fluid 140 through the first semipermeable membrane 112; and when the body fluid outside the expandable chamber 210 has an osmotic concentration lower than that of the fluid 140, the expandable chamber 210 expands when the fluid 140 in the expandable chamber 210 osmotically absorbs water from the body fluid outside the expandable chamber 210 into the fluid 140 through the second semipermeable membrane 212.

[0058] The plurality of valves include a first valve 132 located between the first expandable chamber 110 and the rigid chamber 120, and a second valve 232 located between the second expandable chamber 210 and the rigid chamber 120. The first valve 132 and the second valve 232 are each configured to have an open position to allow or permit the fluid 140 to flow between the adjacent chambers when the valve is open or in the open position. That is, the first valve 132 located between the expandable chamber 110 and the rigid chamber 120 is configured to allow the fluid 140 to flow between the expandable chamber 110 and the rigid chamber 120 when the first valve 132 is open, and the second valve 232 located between the expandable chamber 210 and the rigid chamber 120 is configured to allow the fluid 140 to flow between the expandable chamber 210 and the rigid chamber 220 when the second valve 232 is open. The plurality of valves further include a third valve 134 located between the rigid chamber 120 and the exterior of the rigid chamber 120 and a fourth valve 234 located between the rigid chamber 120 and the exterior of the rigid chamber 120, wherein the third valve 134 and the fourth valve 234 are separated from each other by the piston 122. The third valve 134 is configured to have an open position, thereby allowing or permitting the fluid 140 to flow from the rigid chamber 120 into the third semi-permeable membrane 124 to discharge water from the implantable device 200 when the third valve 134 is open or in the open position. The fourth valve 234 is configured to have an open position, thereby allowing or permitting the fluid 140 to flow from the rigid chamber 120 into the fourth semi-permeable membrane 224 to discharge water from the implantable device 200 when the fourth valve 234 is open or in the open position.

[0059] The implantable device 200 also includes a pump (not shown) as described with reference to the implantable device 100. Likewise, the pump is configured to operate in conjunction with the plurality of valves 132, 134, 232, 234. The pump is configured to move the fluid 140 between the first expandable chamber 110 and the rigid chamber 120 when the first valve 123 is open, and is configured to simultaneously move the fluid 140 from the rigid chamber 120 to the fourth semipermeable membrane 224 when the fourth valve 234 is open. The pump is also configured to move the fluid 140 between the second expandable chamber 210 and the rigid chamber 120 when the second valve 232 is open, and is configured to simultaneously move the fluid 140 from the rigid chamber 210 to the third semipermeable membrane 124 when the third valve 134 is open.

[0060] The piston 122 is configured to perform a pump-actuated pull stroke in the rigid chamber 120 when the first valve 132 and the fourth valve 234 are open so as to simultaneously pull any fluid contents (e.g., fluid 140) from the first expandable chamber 110 into the rigid chamber 120 adjacent to the first expandable chamber 110 and push any fluid contents (e.g., fluid 140 from the rigid chamber 120 adjacent to the expandable chamber 210) through the fourth semipermeable membrane 224 to expel water from the implantable device 200. The piston 122 is also configured to perform a pump-actuated push stroke in the rigid chamber 120 when the second valve 232 and the third valve 134 are open so as to simultaneously push any fluid contents (e.g., fluid 140) from the rigid chamber 120 adjacent to the first expandable chamber 110 through the third semipermeable membrane 124 to expel water from the implantable device 200, and pull any fluid contents (e.g., fluid 140) from the second expandable chamber 210 into the rigid chamber 120 adjacent to the second expandable chamber 210. Similar to the pump-actuated push stroke described with reference to the implantable device 100, the aforementioned pump-actuated stroke can be further utilized with timely opening and closing of valves to push the retentate of fluid 140 from the rigid chamber 120 into the expandable chambers 110, 210 for additional cycles. Additionally, the aforementioned pump-actuated stroke can be further utilized in a cyclic operation mode similar to the implantable device 100.

[0061] The pore sizes of the first semipermeable membrane 112, the second semipermeable membrane 124, the third semipermeable membrane 212, and the fourth semipermeable membrane 224 of the implantable devices 100 and 200 allow water to permeate through the semipermeable membrane, but do not allow larger metabolites (e.g., polypeptides or proteins), cell debris (e.g., platelets), or cells (e.g., red blood cells or white blood cells) to pass through the semipermeable membrane. However, the pore sizes of the semipermeable membranes can be adjusted to allow, for example, Na + , K + , Ca 2+ Mg 2+ or Cl -Ions, as well as molecules with molecular weights lower than the aforementioned larger metabolites (such as urea or creatinine) permeate through the semipermeable membrane. Examples of such semipermeable membranes include, but are not limited to, dialysis membranes.

[0062] The fluid 140 or osmotic fluid within the implantable device 100 or 200 can be an aqueous solution of a dissolved polymer, such as poly(ethylene glycol) ("PEG") or sodium polyacrylate, which, based on size, cannot pass through any of the first, second, third, and fourth semipermeable membranes 112, 124, 212, 224. When the implant device 100 or 200 is implanted in a patient, the initial or basal concentration of the dissolved polymer in the fluid 140 is sufficient to generate an osmotic potential to remove water in excess of the patient's needs through the first semipermeable membrane 112 or the second semipermeable membrane 212. That is, the osmotic fluid has an osmotic concentration higher than that of the body fluid, which allows the osmotic fluid to absorb water from the body fluid through the first semipermeable membrane 112 or the second semipermeable membrane 212 when the implant device 100 or 200 is implanted in a patient.

[0063] Implantable device 100 and implantable device 200 are each configured for implantation in at least the peritoneal cavity of a patient to remove water that has accumulated in the patient's peritoneal cavity due to one or more reasons, including hypervolemia or liver disease (a condition known as ascites). The peritoneal cavity is an advantageous location for implantable devices 100, 200 because the patient's movement allows the fluid 140 in the expandable chambers 110, 210 to keep the fluid moving around, thereby facilitating movement, which maintains a concentration gradient that favors osmosis. Additionally, implantable device 100 can shunt to the patient's ureters to drain water beyond the patient's needs through the patient's bladder.

[0064] Because implantable devices 100 and 200 are electrically powered devices, implantable devices 100 and 200 each further include an induction coil (not shown) configured to couple with a complementary induction coil of a companion device (e.g., a bandage) operable to couple with a power supply to charge or power the implantable device by induction. For example, the bandage may be inserted and worn during the day while the patient is resting or at night while the patient is sleeping.

[0065] Although some specific embodiments have been disclosed herein, and although specific embodiments have been disclosed in detail, the specific embodiments are not intended to limit the scope of the concepts provided herein. A person of ordinary skill in the art may conceive of additional adjustments and / or modifications, and in a broader aspect, these adjustments and / or modifications are also included. Therefore, without departing from the scope of the concepts provided herein, it is possible to deviate from the specific embodiments disclosed herein.

Claims

1. An implantable device for treating hypervolemia, comprising: an expandable chamber, the expandable chamber comprising a first semipermeable membrane; a rigid chamber coupled to the expandable chamber, the rigid chamber comprising a piston; a first valve in fluid communication with both the expandable chamber and the rigid chamber, the first valve having an open position to allow fluid to flow between the expandable chamber and the rigid chamber; a second valve in fluid communication with the rigid chamber and an exterior of the implantable device, the second valve comprising a second semipermeable membrane, the second valve having an open position to allow fluid to flow from the rigid chamber to an exterior of the implantable device; a permeate fluid having an osmotic concentration higher than that of a body fluid, the permeate fluid being designed to absorb water from the body fluid through the first semipermeable membrane; and a pump, wherein the pump is designed to move any fluid contents of the implantable device through the second valve in an open position, Wherein the piston is configured to perform a pump-actuated push stroke in the rigid chamber when the second valve is in an open position to push any fluid contents in the rigid chamber and expel permeate from the implantable device.

2. The implantable device of claim 1, wherein the pump is designed to move any fluid contents of the implantable device through the first valve in an open position.

3. An implantable device according to claim 2, wherein the piston is configured to perform a pump-actuated pull stroke in the rigid chamber when the first valve is in an open position to pull any fluid contents of the expandable chamber into the rigid chamber.

4. The implantable device of claim 1, wherein at least one of the first semipermeable membrane or the second semipermeable membrane is a dialysis membrane.

5. The implantable device of claim 1, wherein the infiltrating fluid is an aqueous solution of a dissolved polymer.

6. The implantable device of claim 5, wherein the first semipermeable membrane and the second semipermeable membrane are designed to prevent passage of an aqueous solution of the dissolved polymer.

7. The implantable device of claim 1, wherein the implantable device is configured for implantation in the peritoneal cavity of a patient.

8. The implantable device of claim 7, wherein the implantable device is shunted to the patient's ureter to drain excess water through the bladder.

9. The implantable device of claim 1 further comprising an induction coil configured to couple with a complementary induction coil of a companion device, the companion device being operable to couple with a power supply to charge or power the implantable device by induction.

10. An implantable device for treating hypervolemia, comprising: a first expandable chamber, the first expandable chamber comprising a first semi-permeable membrane; a second expandable chamber, the second expandable chamber comprising a second semi-permeable membrane; a rigid chamber coupled to the first expandable chamber and the second expandable chamber, the rigid chamber comprising a piston; a first valve in fluid communication with both the first expandable chamber and the rigid chamber, the first valve having an open position to allow fluid to flow between the first expandable chamber and the rigid chamber; a second valve in fluid communication with both the second expandable chamber and the rigid chamber, the second valve having an open position to allow fluid to flow between the second expandable chamber and the rigid chamber; a third valve and a fourth valve in fluid communication with the rigid chamber and an exterior of the implantable device, the third valve comprising a third semipermeable membrane, the fourth valve comprising a fourth semipermeable membrane, the third valve and the fourth valve being separated by the piston, the third valve and the fourth valve each having an open position to allow fluid to flow from the rigid chamber to an exterior of the implantable device; a permeate fluid having an osmotic concentration higher than that of a body fluid, the permeate fluid being designed to absorb water from the body fluid through the first semipermeable membrane; and a pump, wherein the pump is designed to move any fluid contents of the implantable device through the third valve in an open position and the fourth valve in an open position, Wherein the piston is configured to perform a pump-actuated push stroke in the rigid chamber to push fluid contents in the rigid chamber and expel permeate from the implantable device when the fourth valve is in an open position and when the third valve is in an open position.

11. The implantable device of claim 10, wherein the pump is designed to move any fluid contents of the implantable device through the first valve in an open position and the second valve in an open position.

12. The implantable device of claim 11, wherein the piston is configured to perform a pump-actuated pull stroke in the rigid chamber when the first valve is in an open position to pull any fluid contents of the first expandable chamber into the rigid chamber.

13. The implantable device of claim 11, wherein the piston is configured to perform a pump-actuated pull stroke in the rigid chamber when the second valve is in an open position to pull any fluid contents of the second expandable chamber into the rigid chamber.

14. The implantable device of claim 10, wherein at least one of the first semipermeable membrane, the second semipermeable membrane, the third semipermeable membrane, and the fourth semipermeable membrane is a dialysis membrane.

15. The implantable device of claim 10, wherein each of the first semipermeable membrane, the second semipermeable membrane, the third semipermeable membrane, and the fourth semipermeable membrane is a dialysis membrane.

16. The implantable device of claim 10, wherein the infiltrating fluid is an aqueous solution of a dissolved polymer.

17. The implantable device of claim 16, wherein the first, second, third and fourth semipermeable membranes are designed to prevent passage of an aqueous solution of the dissolved polymer.

18. The implantable device of claim 10, wherein the implant device is configured for implantation in the peritoneal cavity of a patient.

19. The implantable device of claim 18, wherein the implantable device is shunted to the patient's ureter to drain excess water through the bladder.

20. The implantable device of claim 10, further comprising an induction coil configured to couple with a complementary induction coil of a companion device, the companion device operable to couple with a power supply to charge or power the implantable device by induction.